
Cross-sectoral Coordination Meeting related to Shipment of Materials
IASMED attended a discussion session held by BB Binomika on…
Collaborating with regulators, research institutions, and industry players to advance clinical trials in Indonesia.
Indonesia offers a combination of a large population, untapped research potential, and regulatory support—making it a strategic hub for international-scale clinical trials.
Indonesia has a large and diverse population, making it ideal for population data collection.
There are many tropical and non-tropical diseases that have not been widely explored, offering great potential for clinical studies.
The existence of regulatory frameworks such as CUKB or GCP from BPOM makes Indonesia increasingly trustworthy.
There is already a track record of large-scale clinical trial projects and previous international collaborations.
Join various activities and the latest training sessions from IASMED.
Supporting research and development of clinical trials through trusted professional services.
Good Clinical Practice (GCP) training with official certification.
Development of clinical trial team capabilities and facilities.
Support for the establishment and management of Clinical Research Units.
Testimonials from training participants and strategic partners contributing to building the pharmaceutical research ecosystem in Indonesia.
As a faculty member at the Faculty of Medicine, a clinician, and a researcher in infectious diseases, I highly appreciate the role of IASMED has successfully
Read moreCurrent information on research, training, and developments in the medical field with IASMED.
IASMED attended a discussion session held by BB Binomika on…
IASMED was so honored to be present in RSUP dr.…
It was a truly enriching experience for IASMED to have…
IASMED is thrilled to be hosting Indonesia Town Hall in…
Dapatkan akses ke pelatihan, direktori mitra, dan jaringan profesional terkemuka di bidang studi obat-obatan.
Daftar Sekarang →